Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
I-CANN Japan trial of cannabinoid products for drug-resistant epilepsy
jRCTs031240495Recruiting
- Sponsor
- MHLW Scientific research fund
- Start
- Mar 2025
- Countries
- 1
01
Overview
Open-label, single-arm trial in epilepsy, sponsored by MHLW Scientific research fund. Primary endpoint: Seizure frequency. Started Mar 2025; status: recruiting.
02
Conditions
epilepsy
Beyond the preview
Go deeper on jRCTs031240495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031240495.